-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 15, 2021, at the "2021 China Stroke Conference" sponsored by the National Health Commission’s Stroke Prevention and Treatment Engineering Committee (Brain Prevention Committee), Shanghai Woby Medical and the China Cerebrovascular Disease Specialist Alliance signed a memorandum of cooperation and reached Strategic partnership.
During the cooperation period, the two parties will cooperate on appropriate technical training for stroke prevention and treatment in primary medical institutions, health education and stroke identification programs for stroke prevention and treatment, training on the construction of a stroke clinical treatment database, clinical scientific research and technological innovation practices.
In recent years, stroke health management has entered the public's field of vision and has become a topic of widespread concern.
Professor Li Tianxiao of the Chinese Association of Cerebrovascular Diseases said: “This year marks the tenth anniversary of the establishment of the Brain Defense Committee, and it is also a key time node for the first five years of China’s implementation of the "Healthy China" 2030 Plan.
An Muk, CEO of Warby Medical, said: "Woby Medical's vision is to become the world's most medical technology company that saves the lives of stroke patients.
The strategic cooperation signing ceremony invited relevant leaders of the Brain Defense Committee of the National Health Commission, Professor Zhang Hongqi from Beijing Xuanwu Hospital, Professor Gu Yuxiang from Shanghai Huashan Hospital, Professor Li Tianxiao from Henan Provincial People's Hospital and other experts in the field of neurointervention.